Global Gonadotropin-releasing Hormone Antagonists Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gonadotropin-releasing Hormone Antagonists Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Gonadotropin-releasing Hormone Antagonists by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Gonadotropin-releasing Hormone Antagonists by Country/Region, 2017, 2022 & 2028

2.2 Gonadotropin-releasing Hormone Antagonists Segment by Type

2.2.1 Peptides

2.2.2 Small Molecules

2.3 Gonadotropin-releasing Hormone Antagonists Sales by Type

2.3.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2022)

2.3.2 Global Gonadotropin-releasing Hormone Antagonists Revenue and Market Share by Type (2017-2022)

2.3.3 Global Gonadotropin-releasing Hormone Antagonists Sale Price by Type (2017-2022)

2.4 Gonadotropin-releasing Hormone Antagonists Segment by Application

2.4.1 Prostate Cancer

2.4.2 Endometriosis

2.4.3 Uterine Fibroids

2.4.4 Female Infertility

2.4.5 Others

2.5 Gonadotropin-releasing Hormone Antagonists Sales by Application

2.5.1 Global Gonadotropin-releasing Hormone Antagonists Sale Market Share by Application (2017-2022)

2.5.2 Global Gonadotropin-releasing Hormone Antagonists Revenue and Market Share by Application (2017-2022)

2.5.3 Global Gonadotropin-releasing Hormone Antagonists Sale Price by Application (2017-2022)

3 Global Gonadotropin-releasing Hormone Antagonists by Company

3.1 Global Gonadotropin-releasing Hormone Antagonists Breakdown Data by Company

3.1.1 Global Gonadotropin-releasing Hormone Antagonists Annual Sales by Company (2020-2022)

3.1.2 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Company (2020-2022)

3.2 Global Gonadotropin-releasing Hormone Antagonists Annual Revenue by Company (2020-2022)

3.2.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Company (2020-2022)

3.2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Company (2020-2022)

3.3 Global Gonadotropin-releasing Hormone Antagonists Sale Price by Company

3.4 Key Manufacturers Gonadotropin-releasing Hormone Antagonists Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gonadotropin-releasing Hormone Antagonists Product Location Distribution

3.4.2 Players Gonadotropin-releasing Hormone Antagonists Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Gonadotropin-releasing Hormone Antagonists by Geographic Region

4.1 World Historic Gonadotropin-releasing Hormone Antagonists Market Size by Geographic Region (2017-2022)

4.1.1 Global Gonadotropin-releasing Hormone Antagonists Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Gonadotropin-releasing Hormone Antagonists Annual Revenue by Geographic Region

4.2 World Historic Gonadotropin-releasing Hormone Antagonists Market Size by Country/Region (2017-2022)

4.2.1 Global Gonadotropin-releasing Hormone Antagonists Annual Sales by Country/Region (2017-2022)

4.2.2 Global Gonadotropin-releasing Hormone Antagonists Annual Revenue by Country/Region

4.3 Americas Gonadotropin-releasing Hormone Antagonists Sales Growth

4.4 APAC Gonadotropin-releasing Hormone Antagonists Sales Growth

4.5 Europe Gonadotropin-releasing Hormone Antagonists Sales Growth

4.6 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Growth

5 Americas

5.1 Americas Gonadotropin-releasing Hormone Antagonists Sales by Country

5.1.1 Americas Gonadotropin-releasing Hormone Antagonists Sales by Country (2017-2022)

5.1.2 Americas Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2022)

5.2 Americas Gonadotropin-releasing Hormone Antagonists Sales by Type

5.3 Americas Gonadotropin-releasing Hormone Antagonists Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gonadotropin-releasing Hormone Antagonists Sales by Region

6.1.1 APAC Gonadotropin-releasing Hormone Antagonists Sales by Region (2017-2022)

6.1.2 APAC Gonadotropin-releasing Hormone Antagonists Revenue by Region (2017-2022)

6.2 APAC Gonadotropin-releasing Hormone Antagonists Sales by Type

6.3 APAC Gonadotropin-releasing Hormone Antagonists Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Gonadotropin-releasing Hormone Antagonists by Country

7.1.1 Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2017-2022)

7.1.2 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2022)

7.2 Europe Gonadotropin-releasing Hormone Antagonists Sales by Type

7.3 Europe Gonadotropin-releasing Hormone Antagonists Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gonadotropin-releasing Hormone Antagonists by Country

8.1.1 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2017-2022)

8.1.2 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2022)

8.2 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Type

8.3 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Gonadotropin-releasing Hormone Antagonists

10.3 Manufacturing Process Analysis of Gonadotropin-releasing Hormone Antagonists

10.4 Industry Chain Structure of Gonadotropin-releasing Hormone Antagonists

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Gonadotropin-releasing Hormone Antagonists Distributors

11.3 Gonadotropin-releasing Hormone Antagonists Customer

12 World Forecast Review for Gonadotropin-releasing Hormone Antagonists by Geographic Region

12.1 Global Gonadotropin-releasing Hormone Antagonists Market Size Forecast by Region

12.1.1 Global Gonadotropin-releasing Hormone Antagonists Forecast by Region (2023-2028)

12.1.2 Global Gonadotropin-releasing Hormone Antagonists Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Gonadotropin-releasing Hormone Antagonists Forecast by Type

12.7 Global Gonadotropin-releasing Hormone Antagonists Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Gonadotropin-releasing Hormone Antagonists Product Offered

13.1.3 AbbVie Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 Takeda

13.2.1 Takeda Company Information

13.2.2 Takeda Gonadotropin-releasing Hormone Antagonists Product Offered

13.2.3 Takeda Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Takeda Main Business Overview

13.2.5 Takeda Latest Developments

13.3 Astellas

13.3.1 Astellas Company Information

13.3.2 Astellas Gonadotropin-releasing Hormone Antagonists Product Offered

13.3.3 Astellas Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Astellas Main Business Overview

13.3.5 Astellas Latest Developments

13.4 Kissei

13.4.1 Kissei Company Information

13.4.2 Kissei Gonadotropin-releasing Hormone Antagonists Product Offered

13.4.3 Kissei Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Kissei Main Business Overview

13.4.5 Kissei Latest Developments

13.5 Veru Inc

13.5.1 Veru Inc Company Information

13.5.2 Veru Inc Gonadotropin-releasing Hormone Antagonists Product Offered

13.5.3 Veru Inc Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Veru Inc Main Business Overview

13.5.5 Veru Inc Latest Developments

13.6 Myovant Sciences

13.6.1 Myovant Sciences Company Information

13.6.2 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Offered

13.6.3 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Myovant Sciences Main Business Overview

13.6.5 Myovant Sciences Latest Developments

13.7 AstraZeneca

13.7.1 AstraZeneca Company Information

13.7.2 AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Offered

13.7.3 AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 AstraZeneca Main Business Overview

13.7.5 AstraZeneca Latest Developments

13.8 Ferring Pharmaceuticals

13.8.1 Ferring Pharmaceuticals Company Information

13.8.2 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Offered

13.8.3 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Ferring Pharmaceuticals Main Business Overview

13.8.5 Ferring Pharmaceuticals Latest Developments

13.9 Jiangsu Hengrui Medicine Co

13.9.1 Jiangsu Hengrui Medicine Co Company Information

13.9.2 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Offered

13.9.3 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Jiangsu Hengrui Medicine Co Main Business Overview

13.9.5 Jiangsu Hengrui Medicine Co Latest Developments

14 Research Findings and Conclusion

Table 1. Gonadotropin-releasing Hormone Antagonists Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Gonadotropin-releasing Hormone Antagonists Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Peptides

Table 4. Major Players of Small Molecules

Table 5. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)

Table 6. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2022)

Table 7. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2017-2022) & ($ million)

Table 8. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2017-2022)

Table 9. Global Gonadotropin-releasing Hormone Antagonists Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)

Table 11. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2022)

Table 12. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2017-2022)

Table 13. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2017-2022)

Table 14. Global Gonadotropin-releasing Hormone Antagonists Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Gonadotropin-releasing Hormone Antagonists Sales by Company (2020-2022) & (K Units)

Table 16. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Company (2020-2022)

Table 17. Global Gonadotropin-releasing Hormone Antagonists Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Company (2020-2022)

Table 19. Global Gonadotropin-releasing Hormone Antagonists Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Gonadotropin-releasing Hormone Antagonists Producing Area Distribution and Sales Area

Table 21. Players Gonadotropin-releasing Hormone Antagonists Products Offered

Table 22. Gonadotropin-releasing Hormone Antagonists Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Gonadotropin-releasing Hormone Antagonists Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share Geographic Region (2017-2022)

Table 27. Global Gonadotropin-releasing Hormone Antagonists Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Gonadotropin-releasing Hormone Antagonists Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country/Region (2017-2022)

Table 31. Global Gonadotropin-releasing Hormone Antagonists Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Gonadotropin-releasing Hormone Antagonists Sales by Country (2017-2022) & (K Units)

Table 34. Americas Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2017-2022)

Table 35. Americas Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2017-2022)

Table 37. Americas Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)

Table 38. Americas Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2022)

Table 39. Americas Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)

Table 40. Americas Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2022)

Table 41. APAC Gonadotropin-releasing Hormone Antagonists Sales by Region (2017-2022) & (K Units)

Table 42. APAC Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2017-2022)

Table 43. APAC Gonadotropin-releasing Hormone Antagonists Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2017-2022)

Table 45. APAC Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)

Table 46. APAC Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2022)

Table 47. APAC Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)

Table 48. APAC Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2022)

Table 49. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2017-2022) & (K Units)

Table 50. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2017-2022)

Table 51. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2017-2022)

Table 53. Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)

Table 54. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2022)

Table 55. Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)

Table 56. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Gonadotropin-releasing Hormone Antagonists

Table 66. Key Market Challenges & Risks of Gonadotropin-releasing Hormone Antagonists

Table 67. Key Industry Trends of Gonadotropin-releasing Hormone Antagonists

Table 68. Gonadotropin-releasing Hormone Antagonists Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Gonadotropin-releasing Hormone Antagonists Distributors List

Table 71. Gonadotropin-releasing Hormone Antagonists Customer List

Table 72. Global Gonadotropin-releasing Hormone Antagonists Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Gonadotropin-releasing Hormone Antagonists Sales Market Forecast by Region

Table 74. Global Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Gonadotropin-releasing Hormone Antagonists Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Gonadotropin-releasing Hormone Antagonists Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Gonadotropin-releasing Hormone Antagonists Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Gonadotropin-releasing Hormone Antagonists Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Gonadotropin-releasing Hormone Antagonists Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share Forecast by Application (2023-2028)

Table 92. AbbVie Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 93. AbbVie Gonadotropin-releasing Hormone Antagonists Product Offered

Table 94. AbbVie Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. AbbVie Main Business

Table 96. AbbVie Latest Developments

Table 97. Takeda Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 98. Takeda Gonadotropin-releasing Hormone Antagonists Product Offered

Table 99. Takeda Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Takeda Main Business

Table 101. Takeda Latest Developments

Table 102. Astellas Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 103. Astellas Gonadotropin-releasing Hormone Antagonists Product Offered

Table 104. Astellas Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Astellas Main Business

Table 106. Astellas Latest Developments

Table 107. Kissei Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 108. Kissei Gonadotropin-releasing Hormone Antagonists Product Offered

Table 109. Kissei Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Kissei Main Business

Table 111. Kissei Latest Developments

Table 112. Veru Inc Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 113. Veru Inc Gonadotropin-releasing Hormone Antagonists Product Offered

Table 114. Veru Inc Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Veru Inc Main Business

Table 116. Veru Inc Latest Developments

Table 117. Myovant Sciences Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 118. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Offered

Table 119. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Myovant Sciences Main Business

Table 121. Myovant Sciences Latest Developments

Table 122. AstraZeneca Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 123. AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Offered

Table 124. AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. AstraZeneca Main Business

Table 126. AstraZeneca Latest Developments

Table 127. Ferring Pharmaceuticals Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 128. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Offered

Table 129. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Ferring Pharmaceuticals Main Business

Table 131. Ferring Pharmaceuticals Latest Developments

Table 132. Jiangsu Hengrui Medicine Co Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 133. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Offered

Table 134. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Jiangsu Hengrui Medicine Co Main Business

Table 136. Jiangsu Hengrui Medicine Co Latest Developments

List of Figures

Figure 1. Picture of Gonadotropin-releasing Hormone Antagonists

Figure 2. Gonadotropin-releasing Hormone Antagonists Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gonadotropin-releasing Hormone Antagonists Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Gonadotropin-releasing Hormone Antagonists Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Peptides

Figure 10. Product Picture of Small Molecules

Figure 11. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type in 2021

Figure 12. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2017-2022)

Figure 13. Gonadotropin-releasing Hormone Antagonists Consumed in Prostate Cancer

Figure 14. Global Gonadotropin-releasing Hormone Antagonists Market: Prostate Cancer (2017-2022) & (K Units)

Figure 15. Gonadotropin-releasing Hormone Antagonists Consumed in Endometriosis

Figure 16. Global Gonadotropin-releasing Hormone Antagonists Market: Endometriosis (2017-2022) & (K Units)

Figure 17. Gonadotropin-releasing Hormone Antagonists Consumed in Uterine Fibroids

Figure 18. Global Gonadotropin-releasing Hormone Antagonists Market: Uterine Fibroids (2017-2022) & (K Units)

Figure 19. Gonadotropin-releasing Hormone Antagonists Consumed in Female Infertility

Figure 20. Global Gonadotropin-releasing Hormone Antagonists Market: Female Infertility (2017-2022) & (K Units)

Figure 21. Gonadotropin-releasing Hormone Antagonists Consumed in Others

Figure 22. Global Gonadotropin-releasing Hormone Antagonists Market: Others (2017-2022) & (K Units)

Figure 23. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2022)

Figure 24. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application in 2021

Figure 25. Gonadotropin-releasing Hormone Antagonists Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Company in 2021

Figure 27. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Geographic Region in 2021

Figure 29. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2017-2022)

Figure 30. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country/Region in 2021

Figure 31. Americas Gonadotropin-releasing Hormone Antagonists Sales 2017-2022 (K Units)

Figure 32. Americas Gonadotropin-releasing Hormone Antagonists Revenue 2017-2022 ($ Millions)

Figure 33. APAC Gonadotropin-releasing Hormone Antagonists Sales 2017-2022 (K Units)

Figure 34. APAC Gonadotropin-releasing Hormone Antagonists Revenue 2017-2022 ($ Millions)

Figure 35. Europe Gonadotropin-releasing Hormone Antagonists Sales 2017-2022 (K Units)

Figure 36. Europe Gonadotropin-releasing Hormone Antagonists Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue 2017-2022 ($ Millions)

Figure 39. Americas Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country in 2021

Figure 40. Americas Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country in 2021

Figure 41. United States Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region in 2021

Figure 46. APAC Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Regions in 2021

Figure 47. China Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country in 2021

Figure 54. Europe Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country in 2021

Figure 55. Germany Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country in 2021

Figure 62. Egypt Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Gonadotropin-releasing Hormone Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Gonadotropin-releasing Hormone Antagonists in 2021

Figure 68. Manufacturing Process Analysis of Gonadotropin-releasing Hormone Antagonists

Figure 69. Industry Chain Structure of Gonadotropin-releasing Hormone Antagonists

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles